2-50346867-C-G
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The ENST00000342183.9(NRXN1):c.83G>C(p.Gly28Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000046 in 1,391,592 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G28V) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000342183.9 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- chromosome 2p16.3 deletion syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Pitt-Hopkins-like syndrome 2Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- autismInheritance: AD Classification: MODERATE Submitted by: G2P
- schizophreniaInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000398 AC: 6AN: 150816Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000237 AC: 20AN: 84426 AF XY: 0.000263 show subpopulations
GnomAD4 exome AF: 0.0000467 AC: 58AN: 1240670Hom.: 0 Cov.: 30 AF XY: 0.0000477 AC XY: 29AN XY: 607734 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000398 AC: 6AN: 150922Hom.: 0 Cov.: 32 AF XY: 0.0000814 AC XY: 6AN XY: 73730 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.G28A variant (also known as c.83G>C), located in coding exon 1 of the NRXN1 gene, results from a G to C substitution at nucleotide position 83. The glycine at codon 28 is replaced by alanine, an amino acid with similar properties. This variant has been identified in two individuals with autism spectrum disorder in the literature without a second alteration detected in the NRXN1 gene; in addition, one of these individuals was also heterozygous for a frameshift alteration in the SHANK3 gene (Yan J et al. Neurosci. Lett., 2008 Jun;438:368-70; Boccuto L et al. Eur. J. Hum. Genet., 2013 Mar;21:310-6). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at